Brief: Oramed Announces Joint Venture To Develop And Commercialize Oral Insulin

Oramed Pharmaceuticals

11/02/2025 14:17

Feb 11 (Reuters) - Oramed Pharmaceuticals  ORMP.O :
    * ORAMED ANNOUNCES TRANSFORMATIVE JOINT VENTURE TO
ACCELERATE
DEVELOPMENT AND COMMERCIALIZATION OF ORAL INSULIN
    * ORAMED PHARMACEUTICALS INC - ANNOUNCES JOINT VENTURE WITH
HTIT
TO FORM ORATECH
    * ORAMED PHARMACEUTICALS INC: HTIT TO INVEST $60 MILLION,
ORAMED
TO INVEST $15 MILLION INTO ORATECH
    * ORAMED PHARMACEUTICALS INC - NEW PHASE 3 TRIAL IN U.S.
EXPECTED
TO BEGIN THIS QUARTER
    * ORAMED PHARMACEUTICALS INC: ORAMED SHAREHOLDERS TO RECEIVE
RIGHT
TO A DIRECT STAKE IN ORATECH, EXPECTED TO GO PUBLIC ON NASDAQ
    * ORAMED PHARMACEUTICALS INC - ORATECH TO RECEIVE ROYALTY
PAYMENTS
FROM SALES OF ORAL INSULIN IN CHINA

Source text:  ID:nPn3ZKqvVa 
Further company coverage:  ORMP.O 

 ((Reuters.Briefs@thomsonreuters.com;))